Cancer models from pediatric brain and solid cancers (cmdc)
Active Awarded Last action
- Contract number
- 75N91020F00035
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,593,507
Award facts
- Contract value 100% obligated
- $3,593,507.48 Current and potential, with all options
- Completion date 76% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Terminate for Convenience | -$255,352 | |
| Terminate for Convenience | $0 | |
| Supplemental Agreement for work within scope | $522,295 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $701,651 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $504,803 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $2,120,110 |
Show all 13
About this award
The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 28, 2020, for cancer models from pediatric brain and solid cancers, with a ceiling value of $3,593,507.48 under a cost-plus-fixed-fee pricing structure.
Place of performance is Frederick, MD. The order's ultimate completion date is September 24, 2028. Leidos Biomedical Research Inc. operates as a Federally Funded Research and Development Center contractor for the National Cancer Institute and National Institutes of Health, delivering biomedical research and facilities support services.
Service Contract Inventory data shows actual government-invoiced activity across fiscal years 2021–2024. In FY2024, the most recent reported year, the order engaged 2.4 FTEs across 4,930 contractor hours with a derived government-paid blended rate of $57.26 per hour. A single subcontractor performed 82 percent of contractor hours. Invoiced amounts and labor footprint expanded significantly from FY2021 ($127 thousand, 0.1 FTEs, 143 hours) through FY2023 ($313 thousand, 1.0 FTEs, 2,136 hours), then declined modestly in FY2024 ($282 thousand). The derived hourly rate declined across the period, from $886.60/hr in FY2021 to $57.26/hr in FY2024, reflecting changes in labor composition and subcontractor engagement depth.
Quick answers
Who was awarded contract 75N91020F00035?
75N91020F00035 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 28, 2020.
How much is contract 75N91020F00035 worth?
The government has obligated $3,593,507 on 75N91020F00035.
Is contract 75N91020F00035 an order under another contract?
Yes. 75N91020F00035 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91020F00035 competed?
The extent of competition for 75N91020F00035 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award